ITGAM and colorectal carcinoma: To examine whether in vivo DT treatment could eliminate TAMs in CMT93 graft CRC model, we first injected DT or DTmu at a concentration of 25 ng/g mouse weight one day prior to grafting CMT93 in CD11b-DTR transgenic mice.